A Proof-of-Concept Randomized Controlled Study of Gabapentin: Effects on Cannabis Use, Withdrawal and Executive Function Deficits in Cannabis-Dependent Adults

There are no FDA-approved pharmacotherapies for cannabis dependence. Cannabis is the most widely used illicit drug in the world, and patients seeking treatment for primary cannabis dependence represent 25% of all substance use admissions. We conducted a phase IIa proof-of-concept pilot study to exam...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropsychopharmacology (New York, N.Y.) N.Y.), 2012-06, Vol.37 (7), p.1689-1698
Hauptverfasser: J MASON, Barbara, CREAN, Rebecca, GOODELL, Vivian, M LIGHT, John, QUELLO FARHAD SHADAN, Susan, BUFFKINS, Kimberly, KYLE, Mark, ADUSUMALLI, Murali, BEGOVIC, Adnan, RAO, Santosh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!